Garat C, Jayr C, Eddahibi S, Laffon M, Meignan M, Adnot S
Département de Physiologie, INSERM U 296, CHU Henri Mondor, Créteil, France.
Am J Respir Crit Care Med. 1997 Jun;155(6):1957-64. doi: 10.1164/ajrccm.155.6.9196102.
Nitric oxide (NO) may either protect against or contribute to oxidant-induced lung injury. In this study, we sought to determine whether either inhaled NO in concentration of 10 and 100 parts per million (ppm) or inhibition of endogenous NO formation with L-NG nitroarginine methyl ester (L-NAME) or aminoguanidine alters the extent of lung injury in rats breathing 100% O2. Lung thiobarbituric acid reactive substances (TBARS), wet to dry lung weight ratio (Q(W)/Q(D)), vascular and epithelial permeability (assessed by simultaneous intravenous administration of 131I-labeled albumin and intraalveolar instillation of 125I-labeled albumin), alveolar liquid clearance (evaluated based on the increase in alveolar protein concentration), and lung liquid clearance (gravimetric method) were determined after 40 h exposure to either 100% or 21% O2. Exposure to hyperoxia caused increases in lung TBARS from 10.5 +/- 0.7 to 13.7 +/- 1.5 micromol/mg protein (p < 0.05); in blood hemoglobin concentration (Hb) from 14 +/- 1 g/dl to 17 +/- 1 g/dl (p < 0.05); in the Q(W)/Q(D) ratio from 4.02 +/- 0.3 to 5.31 +/- 0.5 (p < 0.05); and in alveolar-arterial oxygen tension difference from 124 +/- 14 mm Hg to 241 +/- 61 mm Hg (p < 0.05); as well as a decrease in blood pressure, from 131 +/- 15 mm Hg to 72 +/- 26 mm Hg (p < 0.05). Hyperoxia also increased vascular albumin leakage and moderately altered epithelial barrier permeability to protein. Inhalation of 10 ppm NO prevented the increases in TBARS and Q(W)/Q(D), had no effect on the alveolar barrier impermeability to protein, and improved alveolar liquid clearance. Inhalation of 100 ppm NO did not alter the increases in TBARS and Q(W)/Q(D) but increased vascular permeability to protein. Survival of rats exposed to hyperoxia was not improved by inhaled NO. Treatment with L-NAME or aminoguanidine reduced survival. L-NAME, but not aminoguanidine, increased lung TBARs. These results suggest that, depending on its concentration, inhaled NO can either reduce or increase the early consequences of hyperoxic lung injury. Treatment with L-NAME, and to a lesser extent aminoguanidine, worsened hyperoxic lung injury, indicating a protective effect of endogenous NO.
一氧化氮(NO)可能对氧化剂诱导的肺损伤起到保护作用,也可能促使其发生。在本研究中,我们试图确定百万分之十(ppm)和百万分之一百(ppm)浓度的吸入性NO,或者用L-NG硝基精氨酸甲酯(L-NAME)或氨基胍抑制内源性NO的生成,是否会改变吸入100%氧气的大鼠的肺损伤程度。在暴露于100%或21%氧气40小时后,测定肺组织硫代巴比妥酸反应性物质(TBARS)、肺湿重与干重之比(Q(W)/Q(D))、血管和上皮通透性(通过同时静脉注射131I标记的白蛋白和肺泡内滴注125I标记的白蛋白进行评估)、肺泡液体清除率(根据肺泡蛋白浓度的增加进行评估)以及肺液体清除率(重量法)。暴露于高氧环境会导致肺TBARS从10.5±0.7微摩尔/毫克蛋白增加到13.7±1.5微摩尔/毫克蛋白(p<0.05);血血红蛋白浓度(Hb)从14±1克/分升增加到17±1克/分升(p<0.05);Q(W)/Q(D)比值从4.02±0.3增加到5.31±0.5(p<0.05);肺泡-动脉氧分压差从124±14毫米汞柱增加到241±61毫米汞柱(p<0.05);以及血压从131±15毫米汞柱降低到72±26毫米汞柱(p<0.05)。高氧还会增加血管白蛋白渗漏,并适度改变上皮屏障对蛋白质的通透性。吸入10 ppm的NO可防止TBARS和Q(W)/Q(D)增加,对肺泡屏障对蛋白质的不通透性没有影响,并改善肺泡液体清除率。吸入100 ppm的NO不会改变TBARS和Q(W)/Q(D)的增加,但会增加血管对蛋白质的通透性。吸入NO并不能提高暴露于高氧环境的大鼠的存活率。用L-NAME或氨基胍治疗会降低存活率。L-NAME会增加肺TBARs,而氨基胍则不会。这些结果表明,吸入性NO根据其浓度的不同,可能会减轻或加重高氧肺损伤的早期后果。用L-NAME治疗,以及在较小程度上用氨基胍治疗,会使高氧肺损伤恶化,这表明内源性NO具有保护作用。